This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.
Dismiss

Witness in Naver's South Korean criminal trial denies exclusivity terms blocked rival's real-estate information deal

By Jenny Lee ( July 19, 2024, 04:22 GMT | Insight) -- A key witness in the criminal case against South Korean tech giant Naver denied that the company's controversial contract terms were responsible for blocking a potential deal between real-estate content provider R114 and rival portal Daum Kakao. This testimony, delivered at the Seoul Central District Court during the ninth oral hearing in the case, challenges the prosecution's central argument that Naver used anticompetitive clauses between 2015 and 2017 to restrain content providers’ dealings with Daum, thereby hampering the growth of its competitor’s real-estate information service.A key witness in the criminal case against South Korean search giant Naver denied that the company's controversial contract terms were responsible for blocking a potential deal between real-estate content provider R114 and rival portal Daum Kakao....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login